Allergan, Inamed Smooth Out Concerns Over Reloxin
By Erin Coe · May 14, 2007, 12:00 AM EDT
Botox marketer Allergan Inc. and Inamed Corp. have agreed to divest the rights to rival wrinkle buster Reloxin to alleviate concerns over the potential anti-competitive effects of their billion-dollar merger....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login